|
ZNF526 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.81039999997057E-07 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.16919995696696E-09 |
| Normal-vs-Stage2 |
3.878400E-02 |
| Normal-vs-Stage3 |
1.957870E-02 |
| Normal-vs-Stage4 |
5.151200E-04 |
| Stage1-vs-Stage2 |
5.563500E-02 |
| Stage1-vs-Stage3 |
1.484140E-03 |
| Stage1-vs-Stage4 |
1.750420E-01 |
| Stage2-vs-Stage3 |
7.023800E-01 |
| Stage2-vs-Stage4 |
4.773400E-01 |
| Stage3-vs-Stage4 |
1.763410E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.19899999998452E-07 |
| Normal-vs-AfricanAmerican |
8.839800E-03 |
| Normal-vs-Asian |
3.845800E-04 |
| Caucasian-vs-AfricanAmerican |
6.463200E-01 |
| Caucasian-vs-Asian |
1.344610E-01 |
| AfricanAmerican-vs-Asian |
1.208360E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.0765000004247E-07 |
| Normal-vs-Female |
2.18509999999617E-05 |
| Male-vs-Female |
7.073600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.276000E-02 |
| Normal-vs-Age(41-60Yrs) |
3.24059999945447E-08 |
| Normal-vs-Age(61-80Yrs) |
6.26129999999891E-05 |
| Normal-vs-Age(81-100Yrs) |
6.716000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.053200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.695400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.167200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.532100E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.520000E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.397850E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.42949999615283E-08 |
| Normal-vs-Grade 2 |
1.98579999999282E-07 |
| Normal-vs-Grade 3 |
9.87080000000029E-05 |
| Normal-vs-Grade 4 |
1.203590E-02 |
| Grade 1-vs-Grade 2 |
7.275500E-03 |
| Grade 1-vs-Grade 3 |
1.038080E-03 |
| Grade 1-vs-Grade 4 |
3.556300E-04 |
| Grade 2-vs-Grade 3 |
1.564790E-01 |
| Grade 2-vs-Grade 4 |
8.679900E-02 |
| Grade 3-vs-Grade 4 |
4.855000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
9.41199995718733E-09 |
| Normal-vs-ccB subtype |
2.561600E-03 |
| ccA subtype-vs-ccB subtype |
5.642800E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.48300000000357E-05 |
| Normal-vs-N1 |
9.027700E-02 |
| N0-vs-N1 |
8.144200E-01 |
|
|
